249 related articles for article (PubMed ID: 31216857)
1. Current FIGO Staging for Carcinoma of the Cervix Uteri and Treatment of Particular Stages.
Sehnal B; Kmoníčková E; Sláma J; Tomancová V; Zikán M
Klin Onkol; 2019; 32(3):224-231. PubMed ID: 31216857
[TBL] [Abstract][Full Text] [Related]
2. Revised FIGO staging for carcinoma of the cervix uteri.
Bhatla N; Berek JS; Cuello Fredes M; Denny LA; Grenman S; Karunaratne K; Kehoe ST; Konishi I; Olawaiye AB; Prat J; Sankaranarayanan R; Brierley J; Mutch D; Querleu D; Cibula D; Quinn M; Botha H; Sigurd L; Rice L; Ryu HS; Ngan H; Mäenpää J; Andrijono A; Purwoto G; Maheshwari A; Bafna UD; Plante M; Natarajan J
Int J Gynaecol Obstet; 2019 Apr; 145(1):129-135. PubMed ID: 30656645
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
[TBL] [Abstract][Full Text] [Related]
4. The changes in FIGO staging for carcinoma of the cervix uteri.
Sehnal B; Sláma J; Kmoníčková E; Dubová O; Zikán M
Ceska Gynekol; 2019; 84(3):216-221. PubMed ID: 31324113
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
[TBL] [Abstract][Full Text] [Related]
6. [The 2019 FIGO classification for cervical carcinoma-what's new?].
Horn LC; Brambs CE; Opitz S; Ulrich UA; Höhn AK
Pathologe; 2019 Nov; 40(6):629-635. PubMed ID: 31612260
[TBL] [Abstract][Full Text] [Related]
7. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
[TBL] [Abstract][Full Text] [Related]
8. Implications of the revised cervical cancer FIGO staging system.
Bhatla N; Singhal S; Dhamija E; Mathur S; Natarajan J; Maheshwari A
Indian J Med Res; 2021 Aug; 154(2):273-283. PubMed ID: 35295012
[TBL] [Abstract][Full Text] [Related]
9. The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.
McComas KN; Torgeson AM; Ager BJ; Hellekson C; Burt LM; Maurer KA; Werner TL; Gaffney DK
Gynecol Oncol; 2020 Jan; 156(1):85-92. PubMed ID: 31744640
[TBL] [Abstract][Full Text] [Related]
10. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
Fischerová D; Cibula D
Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
[TBL] [Abstract][Full Text] [Related]
12. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
[TBL] [Abstract][Full Text] [Related]
13. Validation of the 2018 FIGO cervical cancer staging system.
Matsuo K; Machida H; Mandelbaum RS; Konishi I; Mikami M
Gynecol Oncol; 2019 Jan; 152(1):87-93. PubMed ID: 30389105
[TBL] [Abstract][Full Text] [Related]
14. Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
Takahashi M; Sakai K; Iwasa N; Wada M; Hino M; Kurahashi T; Ueno M; Nakagawa H
J Obstet Gynaecol Res; 2021 May; 47(5):1871-1877. PubMed ID: 33611822
[TBL] [Abstract][Full Text] [Related]
15. [Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed müllerian tumors. Facts and background].
Horn LC; Schierle K; Schmidt D; Ulrich U; Liebmann A; Wittekind C
Pathologe; 2011 May; 32(3):239-43. PubMed ID: 20084383
[TBL] [Abstract][Full Text] [Related]
16. Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems.
Shin W; Ham TY; Park YR; Lim MC; Won YJ
Sci Rep; 2021 Mar; 11(1):6988. PubMed ID: 33772044
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
18. Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.
Zhang Y; Ding J; Hua K
J Int Med Res; 2022 Jan; 50(1):3000605211067397. PubMed ID: 34986672
[TBL] [Abstract][Full Text] [Related]
19. Significance of tumor size and number of positive nodes in patients with FIGO 2018 stage IIIC1 cervical cancer.
Maeda M; Mabuchi S; Sakata M; Deguchi S; Kakubari R; Matsuzaki S; Hisa T; Kamiura S
Jpn J Clin Oncol; 2024 Feb; 54(2):146-152. PubMed ID: 37935434
[TBL] [Abstract][Full Text] [Related]
20. Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.
Qin F; Pang H; Yu T; Luo Y; Dong Y
Technol Cancer Res Treat; 2022; 21():15330338221086403. PubMed ID: 35341413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
